- Nurse Identifier Benefits CNOs
- Workplace Violence in the ED
- NP Programs Love Med-Challenger
- AI Healthcare Agents
- QUIZ QUESTION!
How Can This Unique Nurse Identifier Benefit CNOs?
The National Council of State Boards of Nursing runs the not-for-profit NCSBN Databank and Nursys online verification and database. As multi-state licensure compacts come into play and educational requirements and licensing complexity grow, the organization is pushing for increased use of its national system. Every nurse who takes the NCLEX is assigned an NCSBN ID.
How Can This Unique Nurse Identifier Benefit CNOs? - Healthleaders
Emergency Nurses Association Launches Crucial Study on Workplace Violence
The Emergency Nurses Association is conducting a large-scale study on workplace violence in emergency nursing (sign-up link available in the article from Daily Nurse). There aren’t any large-scale studies over a long time period, and the last major study concluded in 2010. This study will examine both the types and prevalence of violence in the ED, as well as the institutional response and support available.
Emergency Nurses Association Launches Crucial Study on Workplace Violence - Daily Nurse
  Microsoft Rolls Out New Tools to Build Healthcare AI Agents
Large data center hosting companies are developing tools for distributed AI models and AI hosting. Amazon has Amazon Redrock for hosting models, while Microsoft offers Azure OpenAI and other hosting options.
From a nursing standpoint, most AI applications are aimed at charting and administrative work. Microsoft is teaming up with Epic EHR, and Amazon is working with GE Healthcare, Epic, and others on similar transcription and records management solutions for all clinical levels.
This article provides a general overview of new AI platform services, focusing on the nursing applications of AI. Paperwork appears to be the area where AI may actually prove useful.
23-year-old with type 1 diabetes presenting with large rash
A 23-year-old man from Massachusetts with a history of well-controlled type 1 diabetes mellitus presents with a rash (see Figure).
He is taking insulin for his diabetes, but is on no other medications. He does not recall any tick bites, but he does like to be outdoors. He acknowledges that the outdoor area outdoors he enjoys most is infested with ticks. He is afebrile and does not have any other symptoms or findings on physical examination.
Which of the following is an appropriate next step in this patient’s care?
- Enzyme-linked immunosorbent assay and confirmatory Western blot
- Doxycycline for 10 to 14 days, or amoxicillin or cefuroxime for 14 days
- Doxycycline for 7-14 days
- Amoxicillin for 28 days
|
Follow and message us on social media to receive a discount code to use on your next purchase.
